Abstract:The genetic drivers of cell growth can depend on an interplay of intrinsic factors and environmental context. However, there is often little consideration into how nutrient availability affects the genetic dependencies of proliferating human cells. Moreover, efforts such as DepMap have catalogued cell fitness genes using in vitro CRISPR screens across hundreds of cancer cell lines cultured in traditional media, which poorly replicate nutrient conditions found in the body. We recently tested the hypothesis that the nutrient environment can affect gene essentiality in human cells. By performing CRISPR screens with blood cancer cell lines, we identified sets of genes differentially required for cells cultured in traditional (e.g., RPMI) versus Human Plasma-Like Medium (HPLM). Among the strongest HPLM-essential hits was HK2, which encodes for the glycolytic enzyme hexokinase 2. Notably, most cancer cell lines co-express two hexokinases (HK1; HK2) that can each catalyze the phosphorylation of glucose to glucose-6-phosphate. Interestingly, while these two HKs share high degrees of structural and biochemical similarity, only HK2 deletion had differentially stronger effects in HPLM. Further, both HK1 and HK2 contain an N-terminal region that permits association with the outer mitochondrial membrane (OMM). To investigate the conditional phenotype for loss of HK2, we generated HK2-knockout K562 leukemia cells, which displayed HK1 expression levels comparable to those measured in control cells. We also confirmed that our HK2-knockout cells showed a stronger relative growth defect in HPLM versus RPMI. Importantly, the expression of HK2 cDNA normalized this defect. By contrast, the expression of kinase-dead HK2 did not provide any rescue effects, suggesting that HK activity is required for the conditionally essential role of HK2. We also engineered a cytosol-restricted HK2 by truncating its N-terminal OMM binding region. When we expressed this cDNA in our HK2-knockout cells, we observed complete rescue of the relative growth defect, suggesting that subcellular HK2 activity contributes to conditional HK2 essentiality. We are now purifying mitochondria to ask how the subcellular distributions of HK1 and HK2 vary with nutrient conditions. In addition, we are also comparing the tracing patterns of 13C glucose in HK2-knockout and control cells to ask how HK2 deletion affects glucose utilization. Finally, given that we normalized glucose levels across our screening conditions, we are applying a systematic approach to determine the gene-nutrient interaction that underlies the conditional phenotype for HK2 deletion. Collectively, our data suggest that HK2 serves a non-redundant and conditionally essential role. We expect to generate novel insights into how HK2 supports human cell growth and why this role can further depend on nutrient availability. Citation Format: Kimberly S. Huggler, Kyle M. Flickinger, Jason R. Cantor. HK2 is conditionally essential for growth in human cancer cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6606.

Isolated left ventricular arrhythmogenic dysplasia.

[Clinical and Genetic Analyses of a Family with Atypical Nonketotic Hyperglycinemia Caused by Compound Heterozygous Mutations in the GLDC Gene].

De novo variants in HK1 associated with neurodevelopmental abnormalities and visual impairment

Clinical, Neuroimaging, and Metabolic Footprint of the Neurodevelopmental Disorder Caused by Monoallelic HK1 Variants

Molecular Evolution of the Vertebrate Hexokinase Gene Family: Identification of A Conserved Fifth Vertebrate Hexokinase Gene

Isolation and Characterization of Mutations in the HXK2 Gene of Saccharomyces Cerevisiae.

Clinical report and genetic analysis of a Chinese family with retinitis pigmentosa 79 caused by a novel loss-of-function HK1 variant

Non-coding variants disrupting a tissue-specific regulatory element in HK1 cause congenital hyperinsulinism

Identification and functional analysis of novel SPTB and ANK1 mutations in hereditary spherocytosis patients

Identification of Novel KMT2D Mutations in Two Chinese Children with Kabuki Syndrome: a Case Report and Systematic Literature Review

Two Novel ANK1 Loss-of-function Mutations in Chinese Families with Hereditary Spherocytosis.

Integrative identification of the pathogenic role of a novel G6PD missense mutation c.697G>C

A novel PKLR gene mutation identified using advanced molecular techniques

The Hexokinase 1 5′-UTR Mutation in Charcot–Marie–Tooth 4G Disease Alters Hexokinase 1 Binding to Voltage-Dependent Anion Channel-1 and Leads to Dysfunctional Mitochondrial Calcium Buffering

Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters

Identification of novel mutations in hereditary spherocytosis patients by whole-exome sequencing

Molecular characterization of hexokinase (HK) in Haemaphysalis longicornis and evaluation of HK protein- and DNA-based vaccines against adult ticks

Generation of Anti-Boa Immunoglobulin Antibodies for Serodiagnostic Applications, and Their Use to Detect Anti-Reptarenavirus Antibodies in Boa Constrictor

[Splicing abnormalities caused by a novel mutation in the PHKA2 gene in children with glycogen storage disease type IX]

Phenotypic characterization of congenital hyperinsulinism due to novel activating glucokinase mutations

Abstract 6606: HK2 is conditionally essential for growth in human cancer cells